Staging DLBCL: Bone marrow biopsy or PET-CT?

Abraham Avigdor

doi:10.1182/blood-2013-05-502575

Staging DLBCL: Bone marrow biopsy or PET-CT?

Abraham Avigdor^*

^*Corresponding author for this work

Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Short survey › peer-review

14 Scopus citations

Abstract

In this issue of Blood, Khan and colleagues evaluated the clinical implications of marrow involvement identified by FDG-PET-CT (2-[ ¹⁸F]fluoro-2-deoxy-Dglucose- positron emission tomography combined with computed tomography) vs iliac crest biopsy in newly diagnosed patients with diffuse large B-cell lymphoma (DLBCL). They showed that FDG-PET-CT scanning had a higher level of accuracy for identifying marrow disease than bone marrow (BM) biopsy (BMB). Nevertheless, the identification of BM involvement by histology per se still had a prognostic impact in terms of overall survival (OS) and progression-free survival (PFS).1

Original language	English
Pages (from-to)	4-5
Number of pages	2
Journal	Blood
Volume	122
Issue number	1
DOIs	https://doi.org/10.1182/blood-2013-05-502575
State	Published - 4 Jul 2013
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/blood-2013-05-502575

Cite this

@article{d0a5a6242e124787af19ee4e8782c74a,

title = "Staging DLBCL: Bone marrow biopsy or PET-CT?",

abstract = "In this issue of Blood, Khan and colleagues evaluated the clinical implications of marrow involvement identified by FDG-PET-CT (2-[ 18F]fluoro-2-deoxy-Dglucose- positron emission tomography combined with computed tomography) vs iliac crest biopsy in newly diagnosed patients with diffuse large B-cell lymphoma (DLBCL). They showed that FDG-PET-CT scanning had a higher level of accuracy for identifying marrow disease than bone marrow (BM) biopsy (BMB). Nevertheless, the identification of BM involvement by histology per se still had a prognostic impact in terms of overall survival (OS) and progression-free survival (PFS).1",

author = "Abraham Avigdor",

year = "2013",

month = jul,

day = "4",

doi = "10.1182/blood-2013-05-502575",

language = "אנגלית",

volume = "122",

pages = "4--5",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "1",

}

TY - JOUR

T1 - Staging DLBCL

T2 - Bone marrow biopsy or PET-CT?

AU - Avigdor, Abraham

PY - 2013/7/4

Y1 - 2013/7/4

N2 - In this issue of Blood, Khan and colleagues evaluated the clinical implications of marrow involvement identified by FDG-PET-CT (2-[ 18F]fluoro-2-deoxy-Dglucose- positron emission tomography combined with computed tomography) vs iliac crest biopsy in newly diagnosed patients with diffuse large B-cell lymphoma (DLBCL). They showed that FDG-PET-CT scanning had a higher level of accuracy for identifying marrow disease than bone marrow (BM) biopsy (BMB). Nevertheless, the identification of BM involvement by histology per se still had a prognostic impact in terms of overall survival (OS) and progression-free survival (PFS).1

AB - In this issue of Blood, Khan and colleagues evaluated the clinical implications of marrow involvement identified by FDG-PET-CT (2-[ 18F]fluoro-2-deoxy-Dglucose- positron emission tomography combined with computed tomography) vs iliac crest biopsy in newly diagnosed patients with diffuse large B-cell lymphoma (DLBCL). They showed that FDG-PET-CT scanning had a higher level of accuracy for identifying marrow disease than bone marrow (BM) biopsy (BMB). Nevertheless, the identification of BM involvement by histology per se still had a prognostic impact in terms of overall survival (OS) and progression-free survival (PFS).1

UR - http://www.scopus.com/inward/record.url?scp=84883671531&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-05-502575

DO - 10.1182/blood-2013-05-502575

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.shortsurvey???

C2 - 23828884

AN - SCOPUS:84883671531

SN - 0006-4971

VL - 122

SP - 4

EP - 5

JO - Blood

JF - Blood

IS - 1

ER -

Staging DLBCL: Bone marrow biopsy or PET-CT?

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this